Skip to main content
Download PDF
Download ePub

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

The Journal of Headache and Pain volume 23, Article number: 161 (2022) Cite this article

The Original Article was published on 18 November 2022

Correction: J Headache Pain 23, 142 (2022)

https://doi.org/10.1186/s10194-022-01515-8

Following publication of the original article [1], the author group has identified an error in Fig. 1. The correct figure is given below.

Fig. 1
figure 1

Study design and visit schedule. mo: month; V: visit

Full size image

The original article [1] has been corrected.

Reference

  1. Gantenbein AR, Agosti R, Kamm CP et al (2022) Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. J Headache Pain 23:142. https://doi.org/10.1186/s10194-022-01515-8

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Neurorehabilitation, ZURZACH Care, Bad Zurzach, Switzerland

    Andreas R. Gantenbein & Elisabeth Schäfer

  2. Kopfwehzentrum Hirslanden, Zurich, Switzerland

    Reto Agosti

  3. Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland

    Christian P. Kamm & Christoph J. Schankin

  4. Neurocentre, Luzerner Kantonsspital, Lucerne, Switzerland

    Christian P. Kamm

  5. Center for Pain Medicine, Nottwil, Switzerland

    Gunther Landmann

  6. Department of Neurology, Spital Thun, Thun, Switzerland

    Niklaus Meier

  7. Department of Reproductive Endocrinology, University Hospital Zurich, Zurich, Switzerland

    Gabriele Susanne Merki-Feld

  8. Neurozentrum Bern, Bern, Switzerland

    Jens A. Petersen

  9. Department of Neurology, University Hospital Zurich, Zurich, Switzerland

    Heiko Pohl

  10. Department of Clinical Neurosciences, CHUV, Lausanne, Switzerland

    Philippe Ryvlin

  11. Private Practice, Sion, Switzerland

    Dragana Viceic

  12. Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland

    Chiara Zecca

  13. Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland

    Chiara Zecca

  14. Novartis Pharma Schweiz AG, Rotkreuz, Switzerland

    Ina Meyer & Michael E. Arzt

Authors
  1. Andreas R. Gantenbein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reto Agosti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian P. Kamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gunther Landmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Niklaus Meier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gabriele Susanne Merki-Feld
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jens A. Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Heiko Pohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Philippe Ryvlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Christoph J. Schankin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Dragana Viceic
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Chiara Zecca
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Elisabeth Schäfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Ina Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Michael E. Arzt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas R. Gantenbein.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gantenbein, A.R., Agosti, R., Kamm, C.P. et al. Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. J Headache Pain 23, 161 (2022). https://doi.org/10.1186/s10194-022-01530-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s10194-022-01530-9

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us